IL33 and pancreatic neoplasm: Recently, Ablam and his team discovered that (Alam et al., 2022) the fungal mycobiome species Alternaria alternata is capable of triggering the secretion of IL-33 and the activation of type 2 immunity in pancreatic cancer.